Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis

Background: The coronavirus disease 2019 (COVID-19) has swept the world and led to delays in the treatment of Crohn's disease patients treated with biologics. This study aims to investigate the risk factors for delayed treatment during the epidemic and to observe the short- and long-term influe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Chen, Lulu, Chen, Shuijiao, Liu, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790060/
https://www.ncbi.nlm.nih.gov/pubmed/35096910
http://dx.doi.org/10.3389/fmed.2021.819557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790060/
https://www.ncbi.nlm.nih.gov/pubmed/35096910
http://dx.doi.org/10.3389/fmed.2021.819557

Ejemplares similares